Skip to content. | Skip to navigation

Personal tools

This is SunRain Plone Theme


You are here: Home / Events / WEBINAR - Prof. Jason Locasale: “Diet and metabolic therapeutics in cancer"

WEBINAR - Prof. Jason Locasale: “Diet and metabolic therapeutics in cancer"

Department of Pharmacology and Cancer Biology, Duke University and Department of Molecular and Structural Biochemistry, North Carolina, USA email:
When Sep 20, 2021
from 03:00 PM to 04:00 PM
Where Aula Virtuale Webinar
Contact Name
Contact Phone 081 6132 422
Add event to calendar vCal

Jason W. Locasale, Ph.D. is an internationally recognized scholar and mentor in the field of metabolism focusing on cancer metabolism, metabolomics, nutrition and the metabolic interface of epigenetics. 

He graduated from Rutgers University, Summa Cum Laude with degrees in Chemistry and Physics. He received his Ph.D. at the Massachusetts Institute of Technology with formal training in Chemistry and Biological Engineering.  He has taught and conducted research at Harvard Medical School, Cornell University and now Duke University where he is currently a tenured associate professor.     

 Dr. Locasale has been one of the pioneers the use of metabolomics approaches to study cancer biology and metabolism.  He has made seminal contributions to our understanding of metabolism including the discovery of serine synthesis in cancers, defining the quantitative, mechanistic principles of the Warburg Effect and altered glucose metabolism in cancer, and the role of metabolism in mediating chromatin status and epigenetics, and the role of dietary amino acids in cancer.  His research combines quantitative approaches in metabolomics and mathematical modeling with biochemistry, cell biology and genetics. 

His current research interests are in three areas: 1) Quantitative biology of metabolism, 2) The role of diet and metabolic therapeutics in health and cancer, and 3) The mechanistic basis between the interaction of metabolism and epigenetics. Each of these synergistic areas utilizes the metabolomics technologies and computational approaches that he develops, applies, and disseminates.

As illustrative recognitions, Dr. Locasale currently serves on a number of editorial boards including PLoS Biology and has served numerous advisory roles for industry, philanthropic organization, and government including the National Institutes of Health office of the Director, and the National Cancer Institute.  He has operated a laboratory funded primarily by NIH with foundation awards, training fellowships and core services.  He has authored over 175 publications and numerous textbooks chapters and patents.  He has been invited to named lectures in at least twenty countries across Europe, Asia, the Middle East and the Americas.

Filed under: